Key result
A novel genetic algorithm protocol successfully developed an in silico hiPSC-CM biophysical model that accurately recapitulated experimental action potential parameters and ionic currents.
Why the study?
Formulating in silico biophysical models requires optimization strategies to reproduce experimental phenomena, and robust nonlinear regressive methods are crucial for high-fidelity electrophysiological modeling of hiPSC-CMs.
A novel genetic algorithm protocol successfully developed an in silico hiPSC-CM biophysical model that accurately reproduces experimental action potential metrics, providing a tool for cardiac safety pharmacology and the study of inherited cardiac disorders.
Answers are grounded in this paper and cite their sources.
Advances hiPSC-CM in silico modeling; leaves open validation for clinical translation.
The formulation of in silico biophysical models generally requires optimization strategies for reproducing experimentally observed phenomena. In electrophysiological modeling, robust nonlinear regressive methods are often crucial for guaranteeing high fidelity models. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), though nascent, have proven to be useful in cardiac safety pharmacology, regenerative medicine, and in the implementation of patient-specific test benches for investigating inherited cardiac disorders. This study demonstrates the potency of heuristic techniques at formulating biophysical models, with emphasis on a hiPSC-CM model using a novel genetic algorithm (GA) recipe we proposed. The proposed GA protocol was used to develop a hiPSC-CM biophysical computer model by fitting mathematical formulations to experimental data for five ionic currents recorded in hiPSC-CMs. The maximum conductances of the remaining ionic channels were scaled based on recommendations from literature to accurately reproduce the experimentally observed hiPSC-CM action potential (AP) metrics. Near-optimal parameter fitting was achieved for the GA-fitted ionic currents. The resulting model recapitulated experimental AP parameters such as AP durations (APD 50 , APD 75 , and APD 90 ), maximum diastolic potential, and frequency of automaticity. The outcome of this work has implications for validating the biophysics of hiPSC-CMs in their use as viable substitutes for human cardiomyocytes, particularly in cardiac safety pharmacology and in the study of inherited cardiac disorders. This study presents a novel GA protocol useful for formulating robust numerical biophysical models. The proposed protocol is used to develop a hiPSC-CM model with implications for cardiac safety pharmacology.
No takes yet. Share an insight, caveat, or question.
Akwaboah et al. (2021) studied Computational modeling of human induced pluripotent stem cell-derived cardiomyocytes. Genetic Algorithm-based parameter fitting vs. Experimental patch-clamp data was evaluated on Goodness of fit (R2) and reproduction of action potential metrics. A novel genetic algorithm protocol successfully developed an in silico hiPSC-CM biophysical model that accurately recapitulated experimental action potential parameters and ionic currents.
Synapse has enriched 10 related papers. Consider them for comparative context: